Systemic lupus erythematosus complicated by Crohn’s disease: a case report and literature review

BMC Gastroenterology

Akio Mimori¹  Toshikazu Kano¹  Hiroshi Kaneko¹  Yuko Takahashi¹  Akitake Suzuki¹  Hoshimi Kawaguchi¹  Yo Ueda¹  Hiroyuki Yamashita¹ 

[1] Division of Rheumatic Diseases, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku, Tokyo, 162-8655, Japan

关键词: Infliximab;    Vasculitis;    Non-caseating granuloma;    Cobblestone-like inflammatory polyps;    Aphthous ulcers;    Longitudinal ulcer;    Crohn’s disease (CD);    Systemic lupus erythematosus (SLE);   

Others  :  858273
DOI  :  10.1186/1471-230X-12-174

 received in 2012-05-20, accepted in 2012-11-29,  发布年份 2012

【 摘 要 】

Background

Although patients with systemic lupus erythematosus (SLE) may experience various gastrointestinal disorders, SLE and Crohn’s disease (CD) rarely coexist. The diseases may have gastrointestinal (GI) manifestations, laboratory results, and radiographic findings that appear similar and consequently differentiating between GI involvement in CD and in SLE may be difficult. We present the case of a patient with SLE and CD who developed continuous GI bleeding and diarrhea that was initially treated as SLE-related colitis to little effect.

Case presentation

A 55-year-old Japanese woman with systemic lupus erythematosus (SLE) developed continuous gastrointestinal bleeding and diarrhea since the patient was aged 30 years that was initially treated as SLE-related colitis. Although a longitudinal ulcer and aphthous ulcers in the colon were observed every examination, biopsy showed only mild inflammation and revealed neither granuloma nor crypt abscess. The patient underwent surgery for anal fistulas twice at 50 and 54 years of age and her symptoms were atypical of lupus enteritis. Colonoscopy was performed again when the patient was 55 years of age because we suspected she had some type of inflammatory bowel disease (IBD). Cobblestone-like inflammatory polyps and many longitudinal ulcers were detected between the descending colon and the cecum. Macroscopic examination strongly suggested CD. Histopathological examination revealed non-caseating granuloma and no evidence of vasculitis, consistent with CD. Introduction of infliximab dramatically relieved the patient’s melena and abdominal symptoms.

Conclusion

Diagnostic criteria for CD and SLE overlap, making them difficult to diagnose correctly. It is important to consider CD for patients who have SLE with gastrointestinal manifestations. The pathology of lupus enteritis should be clarified through the accumulation of cases of SLE combined with CD.

【 授权许可】

   
2012 Yamashita et al.; licensee BioMed Central Ltd.

【 图 表 】

【 参考文献 】

• [1]Nitzan O, Elias M, Saliba WR: Systemic lupus erythematosus and inflammatory bowel disease. Eur J Intern Med 2006, 17:313-8.
• [2]Johnson DA, Diehl AM, Finkelman FD, Cattau EL Jr: Crohn’s disease and systemic lupus erythematosus. Am J Gastroenterol 1985, 11:869-70.
• [3]Nagata M, Ogawa Y, Hisano S, Ueda K: Crohn’s disease in systemic lupus erythematosus: a case report. Eur J Pediatr 1989, 148:525-6.
• [4]Buchman AL, Wilcox CM: Crohn's disease masquerading as systemic lupus erythematosus. South Med J 1995, 88:1081-3.
• [5]Nishida Y, Murase K, Ashida R, Sasaki O, Ozono Y, Mizuta Y, Takeshima F, Makiyama K, Kohno S: Familial Crohn's disease with systemic lupus erythematosus. Am J Gastroenterol 1998, 93:2599-601.
• [6]Shimizu T, Nishinarita S, Son K, Tomita Y, Yoshihiro M, Kitamura N, Horie T, Baba M, Hiranuma M: [Crohn's disease with the onset resembling systemic lupus erythematosus]. Nihon Rinsho Meneki Gakkai Kaishi 1999, 22(3):164-9. Japanese
• [7]Su KY, Tsai ST, Tsay SH, Lee HT, Chen WS, Huang DF: A patient with systemic lupus erythematosus and Crohn's disease complicated with massive lower gastrointestinal bleeding, mimicking intestinal vasculitis. Lupus 2008, 17:1049-50.
• [8]Katsanos KH, Voulgari PV, Tsianos EV: Inflammatory bowel disease and lupus: a systematic review of the literature. J Crohns Colitis 2012, 6:735-42.
• [9]Scholrr-Lesnik B, Brand LJ: Selected rheumatologic and dermatologic manifestation of inflammatory bowel disease. J Am Gastoenterol 1988, 83:216-223.
• [10]Dubnow MH, McPherson JR, Bowie EJW: Lupus erythematosus presenting as an acute abdomen. Minn Med 1966, 49:577-579.
• [11]Kurlander DJ, Kirsner J: The association of chronic "nonspecific" inflammatory bowel disease with lupus erythematosus. Ann Int Med 1964, 60:799-813.
• [12]Carr-Locke DL: Sulfasalazine-induced lupus syndrome in a patient with Crohn’s disease. Am J Gastroenterol 1982, 77:614-6.
• [13]Braegger CP, Nicholls S, Murch SH, Stephens S, MacDonald TT: Tumour necrosis factor alpha in stool as a marker of intestinal inflammation. Lancet 1992, 339:89-91.
• [14]Chamouard P, Grunebaum L, Wiesel ML, Freyssinet JM, Duclos B, Cazenave JP, Baumann R: Prevalence and significance of anticardiolipin antibodies in Crohn's disease. Dig Dis Sci 1994, 39:1501-4.
• [15]Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, Rachmilewitz D, Wolf DC, Olson A, Bao W, Rutgeerts P: ACCENT I Study Group. Maintenance infliximab for Crohn’s disease: the ACCENT I randomised trial. Lancet 2002, 359:1541-1549.
• [16]Williams EL, Gadola S, Edwards CJ: Anti-TNF-induced lupus. Rheumatology (Oxford) 2009, 48:716.
• [17]Aringer M, Graninger WB, Steiner G, Smolen JS: Safety and efficacy of tumor necrosis factor α blockade insystemic lupus erythematosus: an open-label study. Arthritis and Rheumatism 2004, 50:3161-3169.
• [18]Zhu LJ, Yang X, Yu XQ: Anti-TNF-alpha therapies in systemic lupus erythematosus. J Biomed Biotechnol 2010, 2010:465898.